Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,869
Closed -$444K 4100
2026
Q1
$444K Sell
3,869
-65,287
-94% -$5.76M ﹤0.01% 3632
2025
Q4
$4.51M Sell
69,156
-96,493
-58% -$7.7M ﹤0.01% 2512
2025
Q3
$13.6M Buy
165,649
+44,131
+36% +$3.18M ﹤0.01% 1678
2025
Q2
$8M Buy
121,518
+66,081
+119% +$4.11M ﹤0.01% 1986
2025
Q1
$3.64M Buy
55,437
+45,266
+445% +$3.07M ﹤0.01% 2538
2024
Q4
$780K Sell
10,171
-945
-9% -$81.6K ﹤0.01% 3350
2024
Q3
$928K Sell
11,116
-194
-2% -$12.9K ﹤0.01% 3254
2024
Q2
$624K Sell
11,310
-2,933
-21% -$159K ﹤0.01% 3351
2024
Q1
$991K Buy
14,243
+10,488
+279% +$665K ﹤0.01% 3173
2023
Q4
$208K Buy
+3,755
New +$169K ﹤0.01% 3720

Other funds holding ACLX

Ameriprise's ACLX Position: Q2 2026 in Review

Ameriprise sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 3,869 shares — an estimated $444K sold.

Ameriprise first reported a position in ACLX in Q4 2023 and held it in 10 quarters. The position peaked at $13.6M in Q3 2025. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • Ameriprise reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 3,869 Arcellx shares in Q2 2026, an estimated $444K.
  • Ameriprise first reported a position in Arcellx in Q4 2023 and held it in 10 quarters.
  • Ameriprise's Arcellx position peaked at $13.6M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.